L'intérêt à découvert pour Virpax Pharmaceuticals donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Virpax Pharmaceuticals. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Virpax Pharmaceuticals (OTC:VRPX) Stock, Rapport sur les intérêts à découvert

Virpax Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals Inc

Roth MKM analyst Jeff Martin maintains Transact Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TACT#NASDAQ">TACT</a>) with a Buy and lowers the price target from $6 to $5.

News

Price Target

Analyst Ratings

TACT

Roth MKM Maintains Buy on Transact Technologies, Lowers Price Target to $5

Lake Street analyst Eric Martinuzzi maintains SoundThinking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSTI#NASDAQ">SSTI</a>) with a Buy and raises the price target from $18 to $20.

SSTI

Lake Street Maintains Buy on SoundThinking, Raises Price Target to $20

Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) will report its<a href="https://www.benzinga.com/quote/CSCO/earnings"> third-quarter earnings</a> Wednesday after the market close, with Wall Street expecting earnings per share of 92 cets and revenue of $14.08 billion.
The stock has climbed 25.4% over the past year, despite being down 3.87% year-to-date and slipping 6.92% in the past month. However, over the last five trading days, Cisco stock has regained 2.53%, and a confluence of bullish technical signals suggests momentum may just be heating up.
Let's take a look at what's propelling Cisco's stock and how the charts are setting up ahead of earnings.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/05/45398341/how-to-earn-500-a-month-from-cisco-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Cisco Stock Ahead Of Q3 Earnings</a>
<h1 class="wp-block-heading">A Strategic AI Infusion</h1>
Cisco just <a href="https://newsroom.cisco.com/c/r/newsroom/en/us/a/y2025/m05/cisco-appoints-kevin-weil-to-its-board-of-directors.html">added</a> a major dose of AI credibility to its board, appointing Kevin Weil, Chief Product Officer at OpenAI, effective May 12. Weil's resume includes product leadership at X (formerly Twitter), Instagram and now OpenAI — the company behind ChatGPT. CEO Chuck Robbins said that Cisco would "leverage his deep expertise in AI and product innovation to guide our strategic initiatives."
That's not all. Cisco also <a href="https://newsroom.cisco.com/c/r/newsroom/en/us/a/y2025/m05/cisco-announces-new-strategic-ai-initiatives-in-the-middle-east.html?source=rss">announced</a> an expanded partnership with Saudi Arabia's HUMAIN AI, aiming to power the Kingdom's AI infrastructure under <a href="https://www.prnewswire.com/news-releases/cisco-expands-partnership-with-saudi-arabia-to-power-the-ai-future-302454263.html">Vision 2030</a>. Additional collaborations with G42 and the AI Infrastructure Partnership (AIP) across the UAE and the U.S. further entrench Cisco in the global AI arms race.
<h1 class="wp-block-heading">Cisco Stock Strongly Bullish Ahead Of Q3 Earnings</h1>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="633" height="488" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14122028/Screenshot-2025-05-14-at-9.31.53-PM.png" alt="" class="wp-image-915348" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14122028/Screenshot-2025-05-14-at-9.31.53-PM.png 633w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14122028/Screenshot-2025-05-14-at-9.31.53-PM-300x231.png 300w" sizes="(max-width: 633px) 100vw, 633px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Cisco stock at $61.38 trades decisively above its eight-, 20-, 50- and 200-day simple moving averages, triggering a string of bullish technical signals. The eight-day SMA sits at $60.30, the 20-day at $58.07, the 50-day at $59.13 and the 200-day at $56.79 — all beneath the current price.
The Moving Average Convergence Divergence (MACD) indicator clocks in at 0.79, further reinforcing the bullish momentum. Meanwhile, the Relative Strength Index (RSI) is at 64.67 — elevated, but not yet in overbought territory.
<h1 class="wp-block-heading">Cisco Analysts See 9% Upside</h1>
Cisco Analysts Ratings &amp; Consensus Estimates: The <a href="https://www.benzinga.com/quote/CSCO/analyst-ratings">consensus rating</a> on Cisco stock stands at Buy, with an average price target of $62.65. Recent bullish sentiment from top Wall Street firms reinforces that view. 
The three most recent analyst updates — from Evercore ISI Group, Rosenblatt and JPMorgan — carry an average price target of $66.67, implying an upside of roughly 8.66% from current levels.
CSCO Price Action: Cisco stock was trading down 1.25% at $61.01 at the time of publication on Wednesday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45405041/ciscos-partners-with-aip-in-latest-ai-push">Cisco&#8217;s Partners With AIP In Latest AI Push</a></li>
</ul>
Photo: Shutterstock

Technicals

Previews

Tech

Trading Ideas

CSCO

Cisco Stock Roars Back On AI Firepower, Saudi Pact — Bullish Breakout Faces Q3 Earnings Test

Roth MKM analyst Jeff Martin upgrades Perion Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PERI#NASDAQ">PERI</a>) from Neutral to Buy and raises the price target from $9 to $14.

Upgrades

PERI

Roth MKM Upgrades Perion Network to Buy, Raises Price Target to $14

Lake Street analyst Jaeson Schmidt maintains BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) with a Buy and raises the price target from $51 to $55.

BKTI

Lake Street Maintains Buy on BK Technologies, Raises Price Target to $55

ABBV

AbbVie Announces That EMRELIS Has Been Granted Accelerated Approval By The FDA For The Treatment Of Adult Patients With Locally Advanced Or Metastatic, Non-Squamous Non-Small Cell Lung Cancer With High C-Met Protein Overexpression  Who Have Received A Prior Systemic Therapy

WIIM

RKLB

Rocket Lab shares are trading higher after the company on Wednesday announced the return of its Pioneer spacecraft for Varda Space Industries.

Lake Street analyst Eric Martinuzzi maintains Perion Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PERI#NASDAQ">PERI</a>) with a Buy and raises the price target from $10.5 to $13.

Lake Street Maintains Buy on Perion Network, Raises Price Target to $13

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) with a Buy and lowers the price target from $20 to $16.

ACRS

HC Wainwright & Co. Maintains Buy on Aclaris Therapeutics, Lowers Price Target to $16

NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) will release its quarterly earnings report on Thursday, 2025-05-15. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate NRX Pharmaceuticals to report an earnings per share (EPS) of $-0.40.
Investors in NRX Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Here's a look at NRX Pharmaceuticals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td>-0.69</td>
<td>-0.58</td>
<td>-0.37</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.77</td>
<td>-0.15</td>
<td>-0.75</td>
<td>-0.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>3.0%</td>
<td>-6.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<h3>Performance of NRX Pharmaceuticals Shares</h3>
Shares of NRX Pharmaceuticals were trading at $2.29 as of May 13. Over the last 52-week period, shares are down 37.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/NRXP/earnings">To track all earnings releases for NRX Pharmaceuticals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

NRXP

Uncovering Potential: NRX Pharmaceuticals's Earnings Preview

cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-15. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect cbdMD to report an earnings per share (EPS) of $-0.36.
cbdMD bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at cbdMD's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td>0</td>
<td>-0.62</td>
<td>-0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.22</td>
<td>-0.18</td>
<td>-0.15</td>
<td>-1.35</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-15.0%</td>
<td>-7.000000000000001%</td>
<td>2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<h3>Market Performance of cbdMD's Stock</h3>
Shares of cbdMD were trading at $1.01 as of May 13. Over the last 52-week period, shares are down 82.75%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/YCBD/earnings">To track all earnings releases for cbdMD visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

YCBD

An Overview of cbdMD's Earnings

Airbnb Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) shares are trending Wednesday following the company's announcement of a <a href="https://www.benzinga.com/general/travel/25/05/45414358/3-airbnb-initiatives-that-could-unleash-growth-opportunities">major platform expansion</a>.
What To Know: The company introduced Airbnb Services and Airbnb Experiences, along with a redesigned app that integrates bookings for homes, services and activities in a single interface.The updates aim to expand Airbnb's business beyond lodging. 
&#8220;Seventeen years ago, we changed the way people travel. More than two billion guests later, Airbnb is synonymous with a place to stay. With the launch of services and experiences, we're changing travel again. Now you can Airbnb more than an Airbnb,&#8221; said Brian Chesky, co-founder and CEO of Airbnb.
Airbnb Services includes offerings like in-home chefs, massages, personal training and spa treatments, launching in 260 cities across 10 categories. Airbnb Services will be available at nearly every price, and many services will offer an entry level below $50.
Airbnb Experiences, reimagined with new standards and original content, allows users to book activities hosted by local experts. Experiences range from cultural tours and culinary workshops to sessions hosted by celebrities. The company is launching Experiences in 650 cities globally and plans to add more offerings daily.
Airbnb also unveiled a redesigned app interface featuring real-time itinerary management, a new Explore tab and improved host tools. The company also rebuilt the app for hosts to include everything needed to manage their homes, services or experiences.
The rollout reflects Airbnb's effort to grow its presence in the broader travel and lifestyle market. Chesky described the expansion as a shift from being a platform for booking stays to one offering a complete trip experience. 
The new features are available starting this week and hots can access upgrades by enrolling in Airbnb Early Access in the app.
ABNB Price Action: Airbnb has a 52-week high of $163.93 and a 52-week low of $99.88. Airbnb shares experienced a significant decline of close to 40% from its highs in February to its lows in early April. The stock has rebounded more than 30% off the April lows. Shares were up 0.47% at $138.70 at the time of publication Wednesday, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45406180/only-half-of-sp-500-stocks-joined-the-tariff-relief-rally-time-to-buy-the-laggards">Only Half Of S&amp;P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? </a></li>
</ul>
Image Via Shutterstock.

Movers

ABNB

What's Going On With Airbnb Stock Today?

Loop Capital analyst Timothy Greaves maintains Porch Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) with a Buy and raises the price target from $6 to $13.

PRCH

Loop Capital Maintains Buy on Porch Group, Raises Price Target to $13

<h3>Gainers</h3>
<ul>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares moved upwards by 66.0% to $1.13 during Wednesday's regular session. The market value of their outstanding shares is at $323.1 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) stock moved upwards by 48.07% to $7.7. The company's market cap stands at $149.9 million. </li>
<li>a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) shares increased by 46.78% to $12.77. The company's market cap stands at $136.5 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) shares rose 40.84% to $0.5. The market value of their outstanding shares is at $17.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock rose 24.15% to $2.93. The market value of their outstanding shares is at $17.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) shares moved upwards by 22.08% to $7.02. The company's market cap stands at $174.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) stock decreased by 77.2% to $3.3 during Wednesday's regular session. The company's market cap stands at $111.3 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) shares declined by 23.58% to $0.94. The company's market cap stands at $8.1 million. </li>
<li>Superior Industries Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUP#NYSE">SUP</a>) stock declined by 23.02% to $0.48. The company's market cap stands at $13.8 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares fell 18.09% to $2.31. The market value of their outstanding shares is at $10.8 million. </li>
<li>GEN Restaurant Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) shares fell 15.87% to $4.24. The market value of their outstanding shares is at $22.7 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) shares declined by 15.29% to $35.91. The company's market cap stands at $6.0 billion. As per the news, the Q1 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

ECDA

GENK

GLBE

LOBO

NEGG

NWTN

RYET

TOPW

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock increased by 176.9% to $0.36 during Wednesday's regular session. The company's market cap stands at $10.2 million. </li>
<li>bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) stock moved upwards by 49.89% to $4.96. The market value of their outstanding shares is at $48.5 million. </li>
<li>Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) stock increased by 41.68% to $9.54. The company's market cap stands at $424.4 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares increased by 36.11% to $2.69. The company's market cap stands at $8.2 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) stock rose 32.0% to $5.94. The company's market cap stands at $111.5 million. </li>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) stock rose 24.61% to $0.12. The company's market cap stands at $7.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares decreased by 54.4% to $0.01 during Wednesday's regular session. </li>
<li>Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) stock decreased by 53.75% to $0.04. The company's market cap stands at $1.0 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock fell 39.83% to $0.22. The market value of their outstanding shares is at $31.3 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>SILO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares fell 23.87% to $0.84. The market value of their outstanding shares is at $3.7 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) stock decreased by 23.56% to $0.25. The market value of their outstanding shares is at $12.1 million. </li>
<li>GRAIL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) stock fell 22.45% to $33.27. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASBP

AXDX

BDSX

BLUE

BMGL

GRAL

KLTO

LUCY

LYRA

PLRZ

SEPN

SILO

12 Health Care Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Swvl Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWVL#NASDAQ">SWVL</a>) stock moved upwards by 30.6% to $4.15 during Wednesday's regular session. The market value of their outstanding shares is at $44.5 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares rose 21.82% to $2.4. The company's market cap stands at $81.3 million. </li>
<li>Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) stock rose 19.57% to $61.48. The company's market cap stands at $3.1 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares moved upwards by 16.86% to $0.95. The market value of their outstanding shares is at $3.9 million. </li>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares rose 15.96% to $3.6. The market value of their outstanding shares is at $146.7 million. </li>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) stock increased by 14.99% to $0.58. The company's market cap stands at $15.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock fell 66.9% to $0.48 during Wednesday's regular session. The company's market cap stands at $57.6 million. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) shares fell 23.75% to $4.85. The company's market cap stands at $62.9 million. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) stock decreased by 21.38% to $1.14. The company's market cap stands at $3.4 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares declined by 19.96% to $0.25. The company's market cap stands at $5.3 million. </li>
<li>Earlyworks Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) stock decreased by 19.88% to $2.0. The market value of their outstanding shares is at $6.0 million. </li>
<li>Hyliion Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#AMEX">HYLN</a>) shares decreased by 17.54% to $1.57. The market value of their outstanding shares is at $275.3 million. The company's, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ELWS

HTCO

HYLN

MCRP

NVVE

PGHL

SGLY

SPCE

SWVL

WLGS

12 Industrials Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) shares increased by 34.8% to $2.27 during Wednesday's regular session. The market value of their outstanding shares is at $109.2 million. As per the press release, Q1 earnings came out today. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares increased by 19.36% to $11.78. The market value of their outstanding shares is at $3.3 billion. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Datavault AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) shares increased by 17.45% to $0.86. The company's market cap stands at $52.5 million. </li>
<li>Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock increased by 17.2% to $45.58. The market value of their outstanding shares is at $27.2 billion. </li>
<li>Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) stock moved upwards by 15.51% to $1.0. The company's market cap stands at $60.0 million. </li>
<li>NETSOL Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTWK#NASDAQ">NTWK</a>) stock moved upwards by 15.46% to $2.89. The market value of their outstanding shares is at $33.8 million. The company's, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock decreased by 33.5% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $59.0 million. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) shares decreased by 32.23% to $1.43. The market value of their outstanding shares is at $19.6 million. </li>
<li>Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) stock declined by 30.46% to $14.89. The market value of their outstanding shares is at $885.2 million. As per the press release, Q3 earnings came out today. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) shares decreased by 29.19% to $1.99. The market value of their outstanding shares is at $13.8 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) stock declined by 18.55% to $0.61. The company's market cap stands at $22.9 million. As per the news, the Q2 earnings report came out today. </li>
<li>SmartKem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTK#NASDAQ">SMTK</a>) stock declined by 17.42% to $1.66. The market value of their outstanding shares is at $6.0 million. As per the news, the Q1 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DAVA

DVLT

GCTS

GRYP

LDTC

NTWK

Next Technology Holding Inc. - Ordinary Shares

NXTT

RGTI

SMCI

SMTK

XTKG

12 Information Technology Stocks Moving In Wednesday's Intraday Session

American Eagle Outfitters Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) issued a profit warning and withdrew its full-year 2025 <a href="https://www.benzinga.com/quote/AEO/earnings">guidance on Tuesday</a>.
The retailer said it expects first-quarter revenue of $1.1 billion, a 5% decline from the prior year. Comparable sales are projected to be down around 3%, with the American Eagle brand down 2% and the Aerie brand down 4%. The company said it anticipates an operating loss of approximately $85 million, or $68 million on an adjusted basis.
American Eagle withdrew its full-year guidance due to broader macroeconomic uncertainty. While American Eagle said it entered the second quarter with better inventory positioning, the company is still actively reviewing its forward strategy and product performance.
American Eagle shares fell 4.8% to trade at $12.11 on Wednesday.
These analysts made changes to their price targets on American Eagle following the announcement.
<ul class="wp-block-list">
<li>BMO Capital analyst Simeon Siegel maintained American Eagle Outfitters with a Market Perform and lowered the price target from $15 to $11.</li>
<li>JP Morgan analyst Matthew Boss maintained the stock with a Neutral and cut the price target from $10 to $9.</li>
</ul>
Considering buying AEO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14130434/image-167-1024x609.png" alt="" class="wp-image-915393" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14130434/image-167-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14130434/image-167-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14130434/image-167-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14130434/image-167.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45403847/coinbase-to-rally-around-17-here-are-10-top-analyst-forecasts-for-wednesday">Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Guidance

Markets

These Analysts Slash Their Forecasts On American Eagle Outfitters

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth downgrades Affimed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) from Buy to Neutral.

Downgrades

AFMD

HC Wainwright & Co. Downgrades Affimed to Neutral

JP Morgan analyst Robbie Marcus maintains NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) with a Overweight and raises the price target from $14 to $16.

NPCE

JP Morgan Maintains Overweight on NeuroPace, Raises Price Target to $16

Press Releases

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Comments

Virpax Pharmaceuticals

Intérêt court

Virpax Pharmaceuticals (OTC:VRPX) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL